Timothy Blackwell Archives
Tracking lung macrophages
May. 4, 2023—A new technique will allow researchers to track subsets of immune cells that patrol and defend the lungs, to better understand the roles of these cells during lung inflammation, infection and injury.
New target for lung fibrosis
Oct. 20, 2022—Blocking thromboxane-prostanoid receptor signaling protected animals from lung fibrosis in preclinical models, suggesting a new treatment for IPF — a chronic, progressive lung disorder that often kills within 3-5 years of diagnosis.
Collaborative Vanderbilt Lung Institute launches
Nov. 18, 2020—Vanderbilt University Medical Center is launching the Vanderbilt Lung Institute (VLI), a unique collaboration between Pulmonary Medicine, Allergy and Thoracic Surgery, designed to provide coordinated care for patients with all types of respiratory diseases. The Vanderbilt Lung Institute One Hundred Oaks Clinic opened in November, a 10,725-square-foot space including 16 exam rooms and five patient...
Team tracks integrin’s role in lung function
Feb. 6, 2020—Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.
15 faculty members elected as AAAS fellows
Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.
New Physician Science Doctoral Program graduates first student
Feb. 2, 2017—As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke.
Grant spurs study of novel imaging technique for COPD
Sep. 15, 2016—Vanderbilt researchers have received an R01 grant from the National Institutes of Health to study a novel non-invasive imaging approach to detect activation of inflammatory cells in the lungs of patients with chronic obstructive pulmonary disease (COPD), a progressive lung condition that makes breathing difficult.
Major grant enhances pulmonary fibrosis research
Aug. 18, 2016—Vanderbilt University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF).
Study links COPD with increased bacterial invasion
Apr. 28, 2016—Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD.
Integrin discovery may lead to better lung treatments
Jan. 8, 2015—Vanderbilt University researchers have made an important advance in understanding lung development, which one day could lead to improvements in treating lung disease in premature infants and adults.
New group of faculty endowed chairs celebrated
Sep. 28, 2011—Ten of Vanderbilt’s new endowed chairs were praised as leaders in their fields and on campus during a Sept. 26 ceremony at the Student Life Center.
